Dr. Sumathi Nambiar is Director of the Division of Anti-Infective Products, Office of Antimicrobial Products, since July 2013.
Dr. Nambiar joined the Division of Anti-Infective Products in 2002.
In her current role, Dr. Nambiar provides regulatory oversight for anti-infective products, including antibacterial, antifungal, and antiparasitic drugs.
Dr. Nambiar is board-certified in pediatrics and pediatric infectious diseases.
She completed her pediatric residency at the Inova Fairfax Hospital for Children, VA and her fellowship in pediatric infectious diseases at Children’s National Medical Center, Washington DC. She received her MPH from The George Washington University School of Public Health.